Abstract:Background Anti-tumor necrosis factor alpha (TNF- α ) therapy has made a significant impact on treating psoriasis. Despite these agents being designed to block TNF- α activity, their mechanism of action in the remission of psoriasis is still not fully understood at the molecular level. Results To better understand the molecular mechanisms of Anti-TNF- α therapy, we analysed the global gene expression profile (using mRNA microarray) in peripheral blood mononuclear cells (PBMCs) that were collected from 6 psoriasis patients before and 12 weeks after the treatment of etanercept. First, we identified 176 differentially expressed genes (DEGs) before and after treatment by using paired t-test. Then, we constructed the gene co-expression modules by weighted correlation network analysis (WGCNA), and 22 co-expression modules were found to be significantly correlated with treatment response. Of these 176 DEGs, 79 DEGs (M_DEGs) were the members of these 22 co-expression modules. Of the 287 GO functional processes and pathways that were enriched for these 79 M_DEGs, we identified 30 pathways whose overall gene expression activities were significantly correlated with treatment response. Of the original 176 DEGs, 19 (GO_DEGs) were found to be the members of these 30 pathways, whose expression profiles showed clear discrimination before and after treatment. As expected, of the biological processes and functionalities implicated by these 30 treatment response-related pathways, the inflammation and immune response was the top pathway in response to etanercept treatment, and some known TNF- α related pathways, such as molting cycle process, hair cycle process, skin epidermis development, regulation of hair follicle development, were implicated. Furthermore, additional novel pathways were also suggested, such as heparan sulfate proteoglycan metabolic process, vascular endothelial growth factor production, whose transcriptional regulation may mediate the response to etanercept treatment. Conclusion Through global gene expression analysis in PBMC of psoriasis patient and subsequent co-expression module based pathway analyses, we have identified a group of functionally coherent and differentially expressed genes (DEGs) and related pathways, which has not only provided new biological insight about the molecular mechanism of anti-TNF- α treatment, but also identified several genes whose expression profiles can be used as potential biomarkers for anti-TNF- α treatment response in psoriasis.

TAZ acting as a potential pathogenic biomarker to promote the development of lichen planus

Anti-TNF- Αtreatment-Related Pathways and Biomarkers Revealed by Transcriptome Analysis in Chinese Psoriasis Patients

Down-regulated expression of transient receptor potential ankyrin 1 in lichen simplex chronicus

Wnt5a Is Involved In The Pathogenesis Of Cutaneous Lichen Planus

Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants

TAZ deficiency exacerbates psoriatic pathogenesis by increasing the histamine-releasing factor

CXCL9, CXCL10, and CCL19 synergistically recruit T-lymphocytes to skin in lichen planus

Enhanced Proliferation and Interleukin-6 Secretion of T Cells Mediated by Overexpression of TRIM21 in the Oral Lesions of Patients with Oral Lichen Planus

The Expression and Significance of TIPE 1 in Lichen Planus

Chromatin accessibility and transcriptome integrative analysis revealed AP-1-mediated genes potentially modulate histopathology features in psoriasis

Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1, ICAM1, and CCL5 up-regulation

Single-cell immune profiling reveals immune responses in oral lichen planus

Inflammatory and immune-related factor Caspase 1 contributes to the development of oral lichen planus

Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1β, ICAM1 and CCL5 up-regulation.

Increased Infiltration of CD11 C+/cd123+ Dendritic Cell Subsets and Upregulation of TLR/IFN-α Signaling Participate in Pathogenesis of Oral Lichen Planus.

Expression of regulatory T cells and Helper T cells 17 in the lesion tissue of oral lichen planus

Enhanced T-cell Proliferation and IL-6 Secretion Mediated by Overexpression of TRIM21 in Oral Lesions of Patients with Oral Lichen Planus.

The expression of Th17/Treg cells in skin lesions during leprosy, and its clinical significance

Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris

Overexpression of Hippo Pathway Effector TAZ in Tongue Squamous Cell Carcinoma: Correlation with Clinicopathological Features and Patients' Prognosis.